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Calypso console was used to shift the patient to the exact 
Isocenter position. The following imaging protocol was 
followed; Day 1-3 CBCT, or until 3 consecutive CBCTs showed 
acceptable bladder fullness and an empty rectum, afterwards 
only 1 CBCT per week. Following a CBCT we would manually 
match the transponders and apply any necessary shifts. The 
discrepancy between the CBCT and the Calypso shifts was 
then noted. We also recorded maximum prostate motion 
shown on the Calypso tracking station during the treatment, 
as well as the time that the beam was held due to prostate 
motion outside of set tolerances.  
Results: The average discrepancy between the Calypso 
transponder match and CBCT in the lateral direction was -
0.09±0.46mm, longitudinal 0.81±0.66mm, and vertical -
0.69±0.68mm. The average prostate motion during irradiation 
was 0.44±0.82mm in the lateral direction, 0.3±1.4mm in the 
longitudinal, and 0.4±2.0mm in the vertical direction. The 
maximum prostate motion recorded was 0.64cm in the 
vertical direction, and was the result of the patient coughing 
during treatment. In this case the beam was held for 120 
seconds, and the patient had to be shifted back to the 
Isocenter. On one other occasion, the beam was held for 5 
seconds before the prostate moved back within tolerance.  
Conclusions: Based on the positioning accuracy that we have 
seen from the Calypso system, we will soon begin to treat 
prostate patients using the SBRT technique. So far, prostate 
motion has been seen to be quite stable during treatment, 
with the largest prostate motion occurring in the vertical 
direction. Our preparations will help us in setting prostate 
SBRT motion tolerances. We will continue to use Calypso for 
positioning and tracking prostate motion. 
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Purpose/Objective: SRS is becoming a standard treatment in 
many departments. However conventional external beam 
treatments such as VMAT are able to deliver similar 
treatments especially for oligometastatic disease to the 
brain. We performed a prospective trial on 10 patients being 
treated for melanoma brain metastases comparing BrainLab’s 
Exactrac Imaging and CBCT, focusing on efficacy, accuracy 
and economic factors. 
Materials and Methods: 10 cases of SRS planned for single 
fraction treatment on a Varian Unique Linear Accelerator 
using the BrainLab Exactrac Imaging System and 6D robotic 
couch were replanned for VMAT treatment on a Varian 21IX 
Linear Accelerator using CBCT imaging on a standard couch. 
Planning and treatment time, imaging accuracy and economic 
factors were assessed. 
Results: Planning time for SRS using BrainLab's iPlan for 
treatment on the Varian Unique machine could take 
anywhere from 3 hours to several days depending on the 
number of metastases, while VMAT planning took less on 
average, around 4 hours regardless of the number of 
metastases. Treatment time using Exactrac Imaging ranged 
from 20 to 45 minutes, with longer treatment times needed 
for patients with multiple metastases. With VMAT, treatment 
times were more consistent with almost all cases taking 30 
minutes to treat regardless of the number of metastases. 
Although treatment time was much quicker, the time to 
acquire the CBCT was longer compared to Exactrac Imaging. 
Accuracy of less than 0.5mm in six planes was achieved on 
BrainLab’s robotic couch which was much better than the 
1mm tolerance on a standard couch for VMAT. 
Conclusions: Comparing iPlan to VMAT, planning times are 
similar unless multiple metastases are being planned in which 
case VMAT is much quicker. Treatment and imaging times are 
similar, however VMAT treatment times were more consistent 
regardless of the number of metastases being treated, this in 
particular is clinically important for work flow of the 
department. The imaging tolerances of CBCT are less 
accurate than Exactrac Imaging and this should be taken into 
account when considering the use of CBCT for SRS brain 
treatments. In our cases corrections could only be accounted 
for x, y and z planes rather than 6 planes which BrainLab’s 
robotic couch offers. The accuracy of Exactrac Imaging, while 
beneficial, may not necessarily be needed for SRS treatments 
of oligometastatic disease to the brain. The use of CBCT for 
imaging is still an efficient and economical substitute for 
radiation therapy centres who do not have access to Exactrac 
Imaging. However it is important that doses are assessed with 
regard to imaging tolerances. 
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Purpose/Objective: Overall survival for lung cancer patients 
is poor partly due to local recurrence. The local control rate 
may be improved by increasing the dose. However, if the 
anatomy of the patient changes during RT these high doses 
can shift into the oesophagus and other mediastinal organs 
increasing the risk of severe toxicity. 
The aim of this study is to identify how much the oesophagus 
moves during the RT course and the impact on the dose 
distribution. 
Materials and Methods: Twenty consecutive lung cancer 
patients treated with chemo-RT were included in this study. 
All patients had a 4D planning-CT scan (p-CT) and two 
additional 4DCT control scans (c-CT) at fraction 10 and 20. 
The patients were treated with a homogeneous dose 
distribution to the target. The maximum dose to the 
oesophagus was equal to the prescribed dose allowing for a 
higher dose to maximum 1 cm3of the oesophagus. For each 
patient, an experienced radiographer contoured the 
oesophagus in two different structures based on the 
recommendations of the Danish Lung Cancer Group. First, the 
full extent of the oesophagus (oes) was contoured, and then 
the oesophagus was contoured in the extent of the tumour 
(oes-T). In the Eclipse registration module, a rigid 6D tumour 
match between the p-CT and each of the c-CT scans was 
performed and the shift of the oesophagus was obtained for 
the segments oes and oes-T. The treatment plan was copied 
to the c-CTs using the 6D registration and the dose was re-
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calculated by using fixed monitor units and the mean and the 
maximum dose to the oesophagus were read out. 
Results: The mean shift of the oesophagus was 7.5 mm ± 5.3 
mm with a maximum shift of 23.3 mm. In seven patients 
shifts above 10 mm was observed in one or both control 
scans. The mean shift in the region of the tumour was 3.8 
mm ± 3.0 mm with a maximum shift of 13.5 mm. Two 
patients showed shifts of the oesophagus above 10 mm and in 
both patients an atelectasis disappeared during the 
treatment course, whereby the anatomy of the patient 
changed. The mean dose to the oesophagus at the region of 
the tumour (eso-T) increased by 0.4% ± 4.4% when the plan 
was evaluated at the control scans. In three patients, an 
increase in mean dose above 5% was observed. These patients 
have anatomically changes such as pneumonia and 
atelectasis. The maximum dose increased by 1.3% ± 2.6%, 
with a maximum increase of 10% in one patient. In this 
patient only minor anatomical changes are observed. 
Conclusions: The oesophagus moves during the RT course. In 
three patients, the mean dose to the oesophagus in the 
tumour region increases with more than 5 % which can 
correlate with shifts above 10 mm of the oesophagus in two 
of the patients. Patients with anatomical changes like 
disappearance of an atelectasis are more likely to receive an 
increased dose to the oesophagus during the RT course. In 
the case of dose escalation, these patients may benefit from 
an adaptive treatment plan during treatment to avoid severe 
oesophageal toxicity. 
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Purpose/Objective: To compare the accuracy of our 
conventional set-up technique using MV imaging to an optical 
surface monitoring set up (OSMS®, Varian) for the treatment 
of breast cancer patients. Additionally, we evaluated possible 
changes in breast shape during the course of treatment. 
Materials and Methods: 7 breast cancer patients were 
treated using 3D tangential fields. Patients were positioned 
supine on the breast board according to the external 
isocenter marks. MV imaging and bone match on the chest 
wall was done to adjust the position. To track the patients' 
shifts during the matching procedure, OSMS was used. The 
OSMS system consists of 6 cameras, which acquire the 
patients' position in 2D, and a computer vision algorithm, 
which reconstructs the image in 3D. The patients' reference 
surface was imported from the CT scan and the region of 
interest of the treated area was selected. Before and after 
applying the table shifts based on the 2D MV match, the 
treatment surface was captured in order to monitor the OSMS 
corrections in all the translational and rotational directions. 
The OSMS deltas were compared before performing the couch 
and MV imaging shifts. Additionally, the difference between 
the OSMS deltas were calculated, before and after the couch 
shifts, and then compared to the MV imaging shifts. 
Results: Mean shift difference between MV and OSMS in the 
vertical axis was: 2.3mm ± 2.1mm, in the longitudinal axis 
1.9mm ± 2.9mm, in the lateral axis 0.9mm ± 4.2mm. The 
maximum differences were as follows: vertical 8.0mm, 
longitudinal 8.4mm, and lateral 13.2mm.OSMS showed 
rotation up to 3.5°, roll to 4.6°, and pitch 3.1°. 6 out of 7 
patients showed differences less than 1cm between the 
imaging techniques, which were attributed to changes based 
on swelling and arm position. One patient showed a mean 
lateral discrepancy of 9.3mm during the 13 fractions, which 
was most likely due to a variation in roll and rotation at the 
initial CT. The mean absolute difference between the shift 
registered by OSMS after performing the couch movement 
and the shift from MV imaging was: 0.93mm ± 0.78mm in the 
vertical direction, 0.94mm ± 0.75mm in the longitudinal, and 
0.7mm ± 1.0mm in the lateral. 
Conclusions: The OSMS system is helpful in detecting 
differences between treatment and initial setup during CT 
simulation such as arm position or patient rotation. 
Additionally, changes to the breast, such as swelling, can be 
detected. This is especially important if intensity modulated 
techniques are applied. Therefore, using OSMS as an 
additional device to monitor interfractional motion provides 
useful information leading to more precise positioning of the 
patients. This may eventually result in being able to apply 
tighter margins. 
   
PO-1114   
A multidisciplinary developed optimized imaging strategy 
for frameless stereotactic radiosurgery 
M. McGarry1, T. El Kaissi1, J. Hayes1, M. Riyas1, K. Benson1, S. 
Paloor1, J. McLellan1, S. Sheim1, G. Perkins1, R. Hammoud1, 
P. Petric1, N. Al-Hammadi1 
1Hamad Medical Corporation Al Amal Oncology Centre, 
Radiation Oncology, Doha, Qatar  
 
Purpose/Objective: To determine the optimum online 
imaging strategy for frameless SRS using ExacTrac based on 
system accuracy, clinically observed discrepancies between 
imaging methods and intrafraction motion of the patient in 
the frameless mask. 
Materials and Methods: The ExacTrac (ET) system was 
calibrated using the Winston Lutz test to match the ET 
imaging and treatment isocenters to within sub-millimeter 
accuracy as part of acceptance and commissioning. This 
provided a benchmark for our imaging system. A task based 
approach was adopted to develop an optimised imaging 
strategy and associated work instructions. A pilot protocol 
was implemented for six patients, in which both online cone 
beam CT (CBCT) and ET based x-ray verification was 
performed for 24 fractions, with six degrees of freedom 
within the Brainlab system. From analysis of this data, the 
imaging strategy was amended and ET only based verification 
was then carried out for a further 14 patients. In addition, 
intrafraction motion was determined for 89 fractions 
quantifying the stability of the masking system and the 
frequency of verification imaging required. 
Results: The benchmarking QA process determined typical 
deviations of ~0.5mm between the radiation and imaging 
isocentres. Agreement between CBCT and ET verification was 
less than 0.6mm and 0.5degrees which improved our 
confidence with the procedure (Fig.1). 
